Relationship between the expression of RASSF1A protein and promoter hypermethylation of RASSF1A gene in bladder tumor

Abstract

To investigate the relationship between the expression of RASSF1A protein and promoter hypermethylation of RASSF1A gene, RASSF1A protein expression was measured by Western blotting in 10 specimens of normal bladder tissues and 23 specimens of bladder transitional cell carcinoma (BTCC). The promoter methylation in BTCC and normal bladder tissues was detected by methylation-specific PCR (MSP). The results showed that the expression level of RASSF1A protein was significantly lower in BTCC tissues than that in normal bladder tissues. However, it was not correlated with its clinical stages and pathological grades. The frequency of promoter methylation of RASSF1A gene was higher in BTCC tissues than that in normal bladder tissues. In 14 patients with the aberrant promoter methylation, 13 showed loss or low expression of RASSF1A protein. It is concluded that RASSF1A gene promoter methylation may contribute to the low level or loss of RASSF1A protein expression, the inactivation of RASSF1A gene and the genesis of BTCC. But, it may bear no correlation with its clinical stages and pathological grades.

Keywords

bladder transitional cell carcinoma / DNA methylation / Western-blotting / RASSF1A gene

References

[1] SpugnardiM., TommasiS., DammannR., et al.. Epigenetic inactivation of RAS association domain family Protein1 (RASSF1A)in malignant cutaneous melanoma. Cancer Res, 2003, 63(7): 1639-1643

[2] SchagdarsurenginU., GimmO., Hoang-VuC., et al.. Frequent epigenetic silencing of the CPG island Promoter of RASSF1A in thyroid carcinoma. Cancer Res, 2002, 62(13): 3698-3701

[3] DammannR., YangG., PfeiferG. P.. Hypermethylation of the CPG island of Ras association domain family 1 A (RASSF1A), a Putative tumor suppressor gene from the 3P21.3 locus, occurs in a large percentage of human breast Cancer. Cancer Res, 2001, 61: 3105-3109

[4] DammannR., LiC., YoonJ. H., et al.. Epigenetic inactivation of a Ras association domain family Protein from the Lung tumor suppressor Locus 3P21.3. Net Genet, 2002, 25(3): 315-319

[5] ShivakumarL., MinnaI., SakamakiT., et al.. The RASSF1A tumor suppressor block cell cycle Progression and inhibits cyclin D1 accumulation. MoL Cell Biol, 2002, 22(12): 4309-4318

[6] VosM. D., EllisC. A., BellA., et al.. Ras use the novel tumor suppressor RASSF1A as an effector to mediate apoptosis. J Biol Chem, 2000, 275: 35669-35672

[7] WangY. M., KimY. H., KimJ. S., et al.. RASSF1A suppresses the C-Jun-NH2-kinase pathway and inhibits cell cycle progression. Cancer Res, 2005, 65(9): 3682-3690

[8] DallolA., AgathanggelouA., FentonS. L., et al.. RASSF1A interacts with microtubule-associated proteins and modulates microtubule dynamics. Cancer Res, 2004, 64(12): 4112-4116

[9] VosM. D., MartinezA., ElamC., et al.. A role for the RASSF1A tumor suppressor in the regulation of tublin polgmerization and genomic stability. Cancer Res, 2004, 64(12): 4244-4250

[10] ChengJ. C., MatsenC. B., GonzalesF. A., et al.. Inhibition of DNA methylation and reactivation of Silence genes by Zebularine. J Natl Cancer Inst, 2003, 95: 399-409